Home
Conditions
Gastrointestinal Neoplasms

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,152 public trials 2,021 recruiting studies

Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, Not Recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations: GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Charlotte, North Carolina, United States

GSK Investigational Site Oklahoma City, Oklahoma, United States

GSK Investigational Site Philadelphia, Pennsylvania, United States

View all 26 locations

View Trial Details

Active, Not Recruiting

The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study

NCT01570010

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Akershus University Hospital Lørenskog, Norway

University of Oslo Oslo, Norway

Oslo University Hospital Oslo, Norway

View Trial Details

Active, Not Recruiting

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

NCT07457541

Conditions: Breast Cancer (Locally Advanced or Metastatic), Breast Diseases, Breast Neoplasms, +29 more
Locations: Tomsk National Research Medical Center of the Russian Academy of Sciences Tomsk, Tomsk Oblast, Russia

View Trial Details

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NCT05144854

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations: National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan

Kanagawa Cancer Center Yokohama, Kanagawa, Japan

Osaki Citizen Hospital Osaki-shi, Miyagi, Japan

Osaka University Hospital Suita-shi, Osaka, Japan

View all 57 locations

View Trial Details

Active, Not Recruiting

The French E3N Prospective Cohort Study

NCT03285230

Conditions: Asthma, Basal Ganglia Diseases, Behavior, +72 more
Locations: Villejuif, France

View Trial Details

Active, Not Recruiting

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

NCT05426005

Conditions: Colonic Diseases, Colorectal Cancer Stage IV, Colorectal Neoplasms, +13 more
Locations: The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

NCT04929392

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +31 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

NCT03872947

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

AOA-HOPE Tucson, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

HOAG Memorial Hospital Presbyterian Newport, California, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

NCT05843188

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Sunnybrook Odette Cancer Centre Toronto, Ontario, Canada

Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

NCT05143970

Conditions: Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +48 more
Locations: Institut Paoli Calmettes Marseille, France

View Trial Details

Gastrointestinal Neoplasms

Gastrointestinal Neoplasms trial results

Related conditions